The COVID-19 pandemic has highlighted significant gaps and oversights in the administration of antibiotics, resulting chiefly from a lack of knowledge. This misuse of antibiotics has fueled antimicrobial resistance, highlighted the urgent need for better understanding among healthcare professionals and the general public, and has raised the alarm for potential future bacterial or viral pandemics.
Overprescription of antibiotics for COVID-19, borne out of the absence of a specific treatment and a limited timeframe for the development of evidence-based strategies, has resulted in numerous drawbacks including inflated healthcare costs, amplified antimicrobial resistance, and in some scenarios, an increased mortality rate.
Antimicrobial drugs play a pivotal role in modern medicinal practices and contribute substantially to sustainable healthcare systems. They become lifesavers when prescribed judiciously and equally, but resistance develops when these drugs are misused, rendering some infections difficult to treat with the available pharmaceuticals.
The pandemic has accelerated the growth of antimicrobial resistance primarily due to misinformation or lack of knowledge and widespread fear.
Notably, in India, antibiotics such as azithromycin saw a surge in usage, consistent with the rise of COVID-19. Overreliance on broad spectrum agents such as carbapenems became standard practice among hospitalized patients, largely driven by panic and insufficient precautionary measures. Such practices were exacerbated by emerging knowledge of the commonality of fungal infections in critically ill COVID-19 patients.
Worryingly, the overuse of antibiotics hindered infection control and prevention practices, placing significant pressure on health systems and financial resources.
To avoid future escalation, it is crucial to instill a sense of responsibility and rationality in the usage of antimicrobials across hospitals and communities. This will require comprehensive education outreach and increased awareness both among physicians and the general public.
Promoting the effective practice of antimicrobial stewardship at all echelons of public healthcare systems can significantly help in curbing antimicrobial resistance. It will involve targeted training, smarter investment in diagnostic facilities, consistent guidelines implementation and most importantly, integrating antimicrobial stewardship into undergraduate and post-graduate medical education.
In the face of waning power of antibiotics to treat infections, scientists worry about future pandemics – bacterial or viral – with secondary bacterial infections resistant to our existing stock of antimicrobials. Increasing our investment in healthcare to provide skilled human resources, well-equipped laboratories, and generating awareness about the superbugs’ threat is crucial in pandemic-proofing our existing crisis.
Source: https://www.eastmojo.com/health/2023/09/03/what-covid-19-taught-us-about-antibiotics-misuse/